BIOMAT Database Logo BIOMAT Database Logo

[Synthesis and antitumor activities of pyrimidines]. 2011

Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
College of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China. youww@fimmu.com

OBJECTIVE To synthesize cyclin-dependent kinase (CDKs) inhibitors and assay their antitumor activities. METHODS A series of pyrimidines containing different arylamino and 1-(methylsulfonyl)piperidin moieties were designed by combining the segments 1-(methylsulfonyl)piperidin and pyrimidine heterocycles according to the super-position principle of the reinforcement of biological activities. RESULTS Their structures were characterized by MS and 1H NMR spectra and all the synthesized compounds were screened for their antimicrobial activity with MTT assay. CONCLUSIONS The preliminary bioassay showed that compound 3 b displayed good antitumor activity (IC(50)=13.6 µmol/L). The preliminary structure activity relationship analysis of these analogues suggest that the steric factor may have important impact on the anti-tumor activity.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and antitumor activity of fluorocyclopentenyl-pyrimidines.
January 2007, Nucleosides, nucleotides & nucleic acids,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities.
March 2008, Bioorganic & medicinal chemistry,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.
June 2001, Journal of medicinal chemistry,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and activities of antitumor agents.
March 1979, Journal of medicinal chemistry,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines.
July 1999, Anti-cancer drugs,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Thieno[2,3-d]pyrimidines in the synthesis of antitumor and antioxidant agents.
May 2010, Archiv der Pharmazie,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines.
September 2011, European journal of medicinal chemistry,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and fungicidal activities of new 1,2,4-triazolo[1,5-a]pyrimidines.
August 2009, Chemistry & biodiversity,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
November 2006, Archiv der Pharmazie,
Wen-wei You, and Pei-liang Zhao, and Min Zou, and Zhong-zhen Zhou, and An-na Duan, and Shu-guang Wu
Synthesis and biological evaluation of 2'-substituted-4'-selenoribofuranosyl pyrimidines as antitumor agents.
June 2015, Archives of pharmacal research,
Copied contents to your clipboard!